期刊文献+

SMFF:基于结构的多模态抗原抗体结合亲和力预测方法

SMFF: Structure⁃based multi⁃modal framework for antigen⁃antibody binding affinity prediction
在线阅读 下载PDF
导出
摘要 目前抗原⁃抗体结合亲和力预测的人工智能方法都基于序列或结构的单一建模,难以捕获更全面的信息.因此,提出了一种基于结构的多模态特征融合方法.该方法主要包括三个模块:多模态抗体信息挖掘模块、多模态抗原信息挖掘模块和融合预测模块.在多模态抗体信息挖掘模块中,引入Roformer网络分别提取抗体的重链和轻链信息,同时采用GearNet挖掘抗体的结构信息.随后,借助交叉力注意机制自适应地融合序列和结构信息.在多模态抗原信息挖掘模块中,使用蛋白质大语言模型ESM2(Evolutionary Scale Modeling v2)来实现抗原序列信息的抽取.在融合预测模块中,为了实现全面且高效的亲和力预测协同,基于卷积神经网络(Convolutional Neural Networks,CNN)构建了一个多尺度特征协同提取网络,进一步提升抗体和抗原表示的可判别性.最后,将多尺度的抗体和抗原表示输入融合层,生成稳健的亲和力预测结果.实验结果表明,提出的模型在基准数据集上的表现超越了所有的基线模型,并在独立测试集上表现优异,证明该方法具有强大的预测与泛化能力. Currently,artificial intelligence methods for predicting antigen⁃antibody binding affinity predominantly rely on either sequence⁃based or structure⁃based unimodal modeling approaches,which limit their ability to capture comprehensive interaction information.Therefore,we present a structure⁃based multi⁃modal feature fusion framework for antigen⁃antibody affinity prediction.The framework mainly consists of three components:a multi⁃modal antibody information mining module,a multi⁃modal antigen information mining module,and a fusion prediction module.In the antibody information mining module,we employ the Roformer network to separately extract heavy chain and light chain information while utilizing the GearNet to capture structural information of antibodies.The sequence and structural information is then adaptively fused through a cross⁃attention mechanism.For antigen information extraction,we implement the ESM2(Evolutionary Scale Modeling v2)protein language model to process antigen sequence data.The fusion prediction module incorporates a multi⁃scale feature extraction network based on CNN(Convolutional Neural Networks)to enhance the discriminative power of antibody and antigen representations,enabling comprehensive and efficient affinity prediction.Finally,the multi⁃scale representations of antibodies and antigens are fed into a fusion layer to generate robust affinity prediction results.Experimental results demonstrate that our proposed model surpasses all baseline methods on benchmark datasets and shows excellent performance on independent test sets,demonstrating the method's robust predictive power and generalization capability.
作者 施佳豪 姜舒 鞠恒荣 丁卫平 Shi Jiahao;Jiang Shu;Ju Hengrong;Ding Weiping(School of Artificial Intelligence and Computer Science,Nantong University,Nantong,226019,China)
出处 《南京大学学报(自然科学版)》 北大核心 2026年第1期36-47,共12页 Journal of Nanjing University(Natural Science)
基金 国家自然科学基金(62406153) 江苏省高等学校自然科学研究(23KJB520031) 江苏省高校自然科学研究项目(24KJB520032)。
关键词 抗原-抗体结合亲和力预测 多模态融合 结构信息 注意力机制 antigen-antibody binding affinity prediction multi-modal fusion structural information attention mechanism
  • 相关文献

参考文献7

二级参考文献45

  • 1Pengxuan Zhao,Yuebao Zhang,Wenqing Li,Christopher Jeanty,Guangya Xiang,Yizhou Dong.Recent advances of antibody drug conjugates for clinical applications[J].Acta Pharmaceutica Sinica B,2020,10(9):1589-1600. 被引量:16
  • 2Migone T S, Subramanian G M, Zhong J, et al. Raxibacumab for the treatment of inhalational anthrax. N Engl J Med, 2009, 61(2): 135-144.
  • 3Carter P J. Introduction to current and future protein therapeutics: a protein engineering perspective. Exp Cell Res, 2011, 317:1261-1269.
  • 4WHO. General policies for monoclonal antibodies. INN Working Document 09.251. WHO, 24/06/2009.
  • 5Seifert G, Jesse P, Laengler A, et a1. Molecular mechanisms of mistletoe plant extract- induced apoptosis in acute lymphoblastic leukemia in vivo and in vitro. Cancer Lett, 2008, 264(2): 218-228.
  • 6Tracey D, Klareskog L, Sasso E H, et al. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther, 2008, 117(2):244-279.
  • 7Nurmohamed M T, Dijkmans B A. Are biologics more effective than classical disease- modifying antirheumatic drugs? Arthritis Res Therap, 2008, 10(5): 118.
  • 8Gordon K, Papp K, Poulin Y, et al. Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: results from an open-label extension study for patients from REVEAL. J Am Acad Dermatol, 2012, 66(2):241-251.
  • 9Tonelli F, Giudici F, Asteria C R. Effectiveness and safety of local adalimumab injection in patients with fistulizing perianal Crohn’s disease: a pilot study. Dis Colon Rectum, 2012, 55(8): 870-875.
  • 10Pomirleanu C, Ancu a C, Macovei L, et al. Prospective study of the efficiency and safety of adalimumab in treatment of active established rheumatoid arthritis. Rev Med Chir Soc Med Nat Iasi, 2012, 116(2): 395-400.

共引文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部